Fast-Acting Insulin Aspart in Patients with Type  1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

ConclusionsSwitching to faster aspart was associated with improvements in glycemic control without increasing hypoglycemia in adults with T1D using MDI in this real-world setting.

Source: Diabetes Therapy - July 14, 2023 Category: Endocrinology Source Type: research